Hedyotisol B is primarily studied for its potential biological activities, particularly in the field of natural product-based drug discovery. It has shown promising anti-inflammatory and antioxidant effects in preliminary in vitro studies, making it a candidate for further research in managing oxidative stress-related conditions. Additionally, it exhibits moderate cytotoxic activity against certain cancer cell lines, suggesting possible applications in oncology for developing novel chemotherapeutic agents. Its role in modulating cellular pathways involved in apoptosis and cell proliferation is under investigation. Due to its natural origin and structural complexity, it also serves as a lead compound for synthesizing derivatives with enhanced bioactivity and stability.